Muscle and bone effects of androgen deprivation therapy: current and emerging therapies
出版年份 2014 全文链接
标题
Muscle and bone effects of androgen deprivation therapy: current and emerging therapies
作者
关键词
-
出版物
ENDOCRINE-RELATED CANCER
Volume 21, Issue 5, Pages R371-R394
出版商
Bioscientifica
发表日期
2014-07-24
DOI
10.1530/erc-14-0172
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Lowered testosterone in male obesity: Mechanisms, morbidity and management
- (2014) Mathis Grossmann et al. ASIAN JOURNAL OF ANDROLOGY
- Activity and safety of ODM-201 in patients with progressive metastatic castration-resistant prostate cancer (ARADES): an open-label phase 1 dose-escalation and randomised phase 2 dose expansion trial
- (2014) Karim Fizazi et al. LANCET ONCOLOGY
- Skeletal Response to Resistance and Impact Training in Prostate Cancer Survivors
- (2014) KERRI M. WINTERS-STONE et al. MEDICINE AND SCIENCE IN SPORTS AND EXERCISE
- Romosozumab in Postmenopausal Women with Low Bone Mineral Density
- (2014) Michael R. McClung et al. NEW ENGLAND JOURNAL OF MEDICINE
- Androgens and prostate cancer; pathogenesis and deprivation therapy
- (2013) Mathis Grossmann et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Sarcopenia and change in body composition following maximal androgen suppression with abiraterone in men with castration-resistant prostate cancer
- (2013) C Pezaro et al. BRITISH JOURNAL OF CANCER
- The Effects of Testosterone Deprivation and Supplementation on Proteasomal and Autophagy Activity in the Skeletal Muscle of the Male Mouse: Differential Effects on High-Androgen Responder and Low-Androgen Responder Muscle Groups
- (2013) Carlo Serra et al. ENDOCRINOLOGY
- Effects of Exercise on Treatment-Related Adverse Effects for Patients With Prostate Cancer Receiving Androgen-Deprivation Therapy: A Systematic Review
- (2013) Jason R. Gardner et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase IIA randomized, placebo-controlled clinical trial to study the efficacy and safety of the selective androgen receptor modulator (SARM), MK-0773 in female participants with sarcopenia
- (2013) Dimitris A. Papanicolaou et al. Journal of Nutrition Health & Aging
- Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial
- (2013) Adrian S Dobs et al. LANCET ONCOLOGY
- Gonadal Steroids and Body Composition, Strength, and Sexual Function in Men
- (2013) Joel S. Finkelstein et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sclerostin serum levels in prostate cancer patients and their relationship with sex steroids
- (2013) B. García-Fontana et al. OSTEOPOROSIS INTERNATIONAL
- Effect of Small Molecules Modulating Androgen Receptor (SARMs) in Human Prostate Cancer Models
- (2013) Anna Tesei et al. PLoS One
- Mortality following Hip Fracture in Men with Prostate Cancer
- (2013) Mieke Van Hemelrijck et al. PLoS One
- Impact of androgen deprivation therapy on sexual function
- (2012) Clarisse R Mazzola et al. ASIAN JOURNAL OF ANDROLOGY
- Cognitive changes associated with ADT: a review of the literature
- (2012) Rhoda J Jamadar et al. ASIAN JOURNAL OF ANDROLOGY
- Quality of life issues in men undergoing androgen deprivation therapy: a review
- (2012) Rowan G Casey et al. ASIAN JOURNAL OF ANDROLOGY
- Hematological changes during androgen deprivation therapy
- (2012) Mathis Grossmann et al. ASIAN JOURNAL OF ANDROLOGY
- Muscle function, physical performance and body composition changes in men with prostate cancer undergoing androgen deprivation therapy
- (2012) Thomas W Storer et al. ASIAN JOURNAL OF ANDROLOGY
- Complex Metabolic and Skeletal Changes in Men Taking Long-Term Androgen Deprivation Therapy
- (2012) Stanislav Ziaran et al. Clinical Genitourinary Cancer
- Sclerostin and Dickkopf-1 as Therapeutic Targets in Bone Diseases
- (2012) Hua Zhu Ke et al. ENDOCRINE REVIEWS
- A Phase 3, Double-blind, Randomised, Parallel-group, Placebo-controlled Study of Oral Weekly Alendronate for the Prevention of Androgen Deprivation Bone Loss in Nonmetastatic Prostate Cancer: The Cancer and Osteoporosis Research with Alendronate and Leuprolide (CORAL) Study
- (2012) Laurence H. Klotz et al. EUROPEAN UROLOGY
- Randomized, Double-Blinded, Placebo-Controlled, Trial of Risedronate for the Prevention of Bone Mineral Density Loss in Nonmetastatic Prostate Cancer Patients Receiving Radiation Therapy Plus Androgen Deprivation Therapy
- (2012) Richard Choo et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Sarcopenia During Androgen-Deprivation Therapy for Prostate Cancer
- (2012) Matthew R. Smith et al. JOURNAL OF CLINICAL ONCOLOGY
- The Safety, Pharmacokinetics, and Effects of LGD-4033, a Novel Nonsteroidal Oral, Selective Androgen Receptor Modulator, in Healthy Young Men
- (2012) Shehzad Basaria et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Muscles, exercise and obesity: skeletal muscle as a secretory organ
- (2012) Bente K. Pedersen et al. Nature Reviews Endocrinology
- Targeting the Skeletal Muscle–Metabolism Axis in Prostate-Cancer Therapy
- (2012) Shehzad Basaria et al. NEW ENGLAND JOURNAL OF MEDICINE
- Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
- (2012) Howard I. Scher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Site-specific differential effects of once-yearly zoledronic acid on the hip assessed with quantitative computed tomography: results from the HORIZON Pivotal Fracture Trial
- (2012) L. Yang et al. OSTEOPOROSIS INTERNATIONAL
- Long-term effects of intermittent androgen suppression therapy on lean and fat mass: a 33-month prospective study
- (2012) N A Spry et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Increased adiposity in DNA binding-dependent androgen receptor knockout male mice associated with decreased voluntary activity and not insulin resistance
- (2011) Kesha Rana et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Lifestyle Intervention in Men with Advanced Prostate Cancer Receiving Androgen Suppression Therapy: A Feasibility Study
- (2011) L. Bourke et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Sarcopenia and Obesity
- (2011) Debra L. Waters et al. CLINICS IN GERIATRIC MEDICINE
- High-Dose Adjuvant Radiotherapy After Radical Prostatectomy With or Without Androgen Deprivation Therapy
- (2011) Piet Ost et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Denosumab and changes in bone turnover markers during androgen deprivation therapy for prostate cancer
- (2011) Matthew R Smith et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Androgen Deprivation Therapy as Primary Treatment for Prostate Cancer
- (2011) Dara H. Cannata et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Adjuvant Androgen Deprivation for High-Risk Prostate Cancer After Radical Prostatectomy: SWOG S9921 Study
- (2011) Tanya B. Dorff et al. JOURNAL OF CLINICAL ONCOLOGY
- Body Composition, Physical Fitness, Functional Performance, Quality of Life, and Fatigue Benefits of Exercise for Prostate Cancer Patients: A Systematic Review
- (2011) Justin W.L. Keogh et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Abiraterone and Increased Survival in Metastatic Prostate Cancer
- (2011) Johann S. de Bono et al. NEW ENGLAND JOURNAL OF MEDICINE
- Timing of androgen deprivation therapy use and fracture risk among elderly men with prostate cancer in the United States
- (2011) Jennifer L. Beebe-Dimmer et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Risedronate prevents persistent bone loss in prostate cancer patients treated with androgen deprivation therapy: results of a 2-year follow-up study
- (2011) K Izumi et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Bisphosphonate therapy in patients under androgen deprivation therapy for prostate cancer: a systematic review and meta-analysis
- (2011) A Serpa Neto et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Obese Frailty, Physical Performance Deficits, and Falls in Older Men with Biochemical Recurrence of Prostate Cancer on Androgen Deprivation Therapy: A Case-control Study
- (2011) Kathryn Bylow et al. UROLOGY
- The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial
- (2011) James T. Dalton et al. Journal of Cachexia Sarcopenia and Muscle
- Androgen deprivation therapy in men with prostate cancer: how should the side effects be monitored and treated?
- (2010) Mathis Grossmann et al. CLINICAL ENDOCRINOLOGY
- Structural Decay of Bone Microarchitecture in Men with Prostate Cancer Treated with Androgen Deprivation Therapy
- (2010) E. J. Hamilton et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Impact of Androgen-Deprivation Therapy on Physical Function and Quality of Life in Men With Nonmetastatic Prostate Cancer
- (2010) Shabbir M.H. Alibhai et al. JOURNAL OF CLINICAL ONCOLOGY
- Muscles and their myokines
- (2010) B. K. Pedersen JOURNAL OF EXPERIMENTAL BIOLOGY
- Fracture Types and Risk Factors in Men With Prostate Cancer on Androgen Deprivation Therapy: A Matched Cohort Study of 19,079 Men
- (2010) Shabbir M.H. Alibhai et al. JOURNAL OF UROLOGY
- American College of Sports Medicine Roundtable on Exercise Guidelines for Cancer Survivors
- (2010) Kathryn H. Schmitz et al. MEDICINE AND SCIENCE IN SPORTS AND EXERCISE
- Reimbursement Policy and Androgen-Deprivation Therapy for Prostate Cancer
- (2010) Vahakn B. Shahinian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Titration of Dosage for the Protective Effect of Zoledronic Acid on Bone Loss in Patients Submitted to Androgen Deprivation Therapy due to Prostate Cancer: A Prospective Open-Label Study
- (2010) Paulo Rodrigues et al. UROLOGIA INTERNATIONALIS
- A phase III clinical trial of exercise modalities on treatment side-effects in men receiving therapy for prostate cancer
- (2009) Robert U Newton et al. BMC CANCER
- A randomized controlled trial of an exercise intervention targeting cardiovascular and metabolic risk factors for prostate cancer patients from the RADAR trial
- (2009) Daniel A Galvão et al. BMC CANCER
- Single infusion of zoledronic acid to prevent androgen deprivation therapy-induced bone loss in men with hormone-naive prostate carcinoma
- (2009) Takefumi Satoh et al. CANCER
- Genetic Disruption of Myostatin Reduces the Development of Proatherogenic Dyslipidemia and Atherogenic Lesions In Ldlr Null Mice
- (2009) P. Tu et al. DIABETES
- Human IL6 enhances leptin action in mice
- (2009) M. Sadagurski et al. DIABETOLOGIA
- Combined Resistance and Aerobic Exercise Program Reverses Muscle Loss in Men Undergoing Androgen Suppression Therapy for Prostate Cancer Without Bone Metastases: A Randomized Controlled Trial
- (2009) Daniel A. Galvão et al. JOURNAL OF CLINICAL ONCOLOGY
- Effects of Denosumab on Bone Mineral Density in Men Receiving Androgen Deprivation Therapy for Prostate Cancer
- (2009) Matthew R. Smith et al. JOURNAL OF UROLOGY
- Intravenous Zoledronic Acid to Prevent Osteoporosis in a Veteran Population With Multiple Risk Factors for Bone Loss on Androgen Deprivation Therapy
- (2009) Nirmala Bhoopalam et al. JOURNAL OF UROLOGY
- Duration of Androgen Suppression in the Treatment of Prostate Cancer
- (2009) Michel Bolla et al. NEW ENGLAND JOURNAL OF MEDICINE
- Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer
- (2009) Matthew R. Smith et al. NEW ENGLAND JOURNAL OF MEDICINE
- Physical activity for men receiving androgen deprivation therapy for prostate cancer: benefits from a 16-week intervention
- (2009) S. Nicole Culos-Reed et al. SUPPORTIVE CARE IN CANCER
- Risedronate Recovers Bone Loss in Patients With Prostate Cancer Undergoing Androgen-deprivation Therapy
- (2009) Kouji Izumi et al. UROLOGY
- Changes in muscle, fat and bone mass after 36 weeks of maximal androgen blockade for prostate cancer
- (2008) Daniel A. Galvão et al. BJU INTERNATIONAL
- Older Men With Low Serum Estradiol and High Serum SHBG Have an Increased Risk of Fractures
- (2008) Dan Mellström et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Approach to the Prostate Cancer Patient with Bone Disease
- (2008) Susan L. Greenspan JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Skeletal Health After Continuation, Withdrawal, or Delay of Alendronate in Men With Prostate Cancer Undergoing Androgen-Deprivation Therapy
- (2008) Susan L. Greenspan et al. JOURNAL OF CLINICAL ONCOLOGY
- Ten-Year Follow-Up of Radiation Therapy Oncology Group Protocol 92-02: A Phase III Trial of the Duration of Elective Androgen Deprivation in Locally Advanced Prostate Cancer
- (2008) Eric M. Horwitz et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Controlled Trial of Resistance or Aerobic Exercise in Men Receiving Radiation Therapy for Prostate Cancer
- (2008) Roanne J. Segal et al. JOURNAL OF CLINICAL ONCOLOGY
- Osteoporosis in Men
- (2008) Peter R. Ebeling NEW ENGLAND JOURNAL OF MEDICINE
- Reduced muscle strength and functional performance in men with prostate cancer undergoing androgen suppression: a comprehensive cross-sectional investigation
- (2008) D A Galvão et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Physical Function Changes in Prostate Cancer Patients on Androgen Deprivation Therapy: A 2-Year Prospective Study
- (2008) Matthew E. Levy et al. UROLOGY
- Falls and Physical Performance Deficits in Older Patients With Prostate Cancer Undergoing Androgen Deprivation Therapy
- (2008) Kathryn Bylow et al. UROLOGY
- Androgen deprivation therapy for prostate cancer: Effects on hand function
- (2007) Feray Soyupek et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started